Hyperprogression after Immunotherapy: Nivolumab. Analysis of Imaging Findings Associated with Hyperprogression and Tumor Growth Kinetics

Introduction The increased use of new checkpoint inhibitors in cancer therapy has led to the discovery of new unconventional responses, like pseudoprogression and hyperprogression disease (HPD). The study documents imaging findings of HPD and analyzes the growth kinetics in advanced metastatic cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Singla, Rishu, Gupta, Ayushi, Batra, Ullas, Chaturvedi, Arvind, Rao, Avinash, Jajodia, Ankush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448245/
https://www.ncbi.nlm.nih.gov/pubmed/34556917
http://dx.doi.org/10.1055/s-0041-1734341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448245/
https://www.ncbi.nlm.nih.gov/pubmed/34556917
http://dx.doi.org/10.1055/s-0041-1734341

Ejemplares similares